Romark Laboratories, L.C.

4830 W Kennedy Blvd Ste 600, Tampa, Florida, United States

Also known as:

romark institute for medical research, the

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

50.0%

Phase 2

43.3%

Not Applicable

3.3%

Trial Status Distribution

Active, not recruiting

3.3%

Completed

66.7%

Not yet recruiting

6.7%

Terminated

20.0%

Unknown

3.3%

Clinical Trials

Trials sponsored by this organization (30)

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Phase 3

Not yet recruiting

interventional

Aug 2024600 participants

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Phase 3

Not yet recruiting

interventional

Aug 20242,000 participants

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Phase 3

Terminated

interventional

Aug 2020214 participants

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Phase 3

Completed

interventional

Aug 2020935 participants

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Phase 3

Completed

interventional

May 20201,407 participants

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

Phase 3

Terminated

interventional

May 2020190 participants

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Phase 2

Completed

interventional

Oct 201951 participants

Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Phase 3

Completed

interventional

Sep 20181,756 participants

Page 1 of 4

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations